“…These data and product usage methods have been used within a screening‐level exposure model to inform chemical prioritization (Isaacs et al., 2014), which had some limitations on the exposure side, including lower‐tier conservative assumptions that do not account for the mass balance nature of competing processes, such as volatilization and dermal uptake on skin surface. On the other hand, more elaborate, higher tier mass balance‐based models have been developed to estimate transport, fate, exposure associated with multiple chemical emissions, and usage along the life cycles of products and services (Csiszar, Ernstoff, Fantke, Meyer, & Jolliet, 2016; Fantke, Ernstoff, Huang, Csiszar, & Jolliet, 2016; Fantke, Huang, Overcash, Griffing, & Jolliet, 2020) for high‐throughput screening of cosmetics, and have been consolidated within an extended USEtox near‐field and far‐field model, but to date have incorporated relatively limited data on chemical and product usage.…”